Our results point to the fact that KLK1, KLK2, and KLK14 (only in recurrent prostate cancer tissues) are underexpressed in prostate cancer tissues, while KLK3, KLK4, KLK8, and KLK9 are overexpressed in both recurrent and non-recurrent tissues. Here, KLK8 is linked to prostate carcinoma.